Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
0.157
-0.008 (-4.96%)
At close: Jun 26, 2026, 4:00 PM EDT
0.163
+0.006 (3.50%)
After-hours: Jun 26, 2026, 7:50 PM EDT
Gossamer Bio Employees
As of December 31, 2025, Gossamer Bio had 162 total employees, including 161 full-time and 1 part-time employees. The number of employees increased by 17 or 11.72% compared to the previous year.
Employees
162
Change (1Y)
17
Growth (1Y)
11.72%
Revenue / Employee
$342,821
Profits / Employee
-$1,113,556
Market Cap
76.75M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Heron Therapeutics | 128 |
| MindWalk Holdings | 102 |
| XBiotech | 87 |
| Acrivon Therapeutics | 76 |
| Elicio Therapeutics | 33 |
| Entera Bio | 22 |
| Gain Therapeutics | 21 |
| iBio, Inc. | 20 |
GOSS News
- 1 day ago - Gossamer Bio price target lowered to $2 from $5 at H.C. Wainwright - TheFly
- 9 days ago - Gossamer Bio announces final tender results - TheFly
- 9 days ago - Gossamer Bio, Inc. Announces Final Tender Results for Exchange Offer and Consent Solicitation with Respect to Existing Convertible Notes - Business Wire
- 17 days ago - Gossamer Bio Proxy statement: Proxy filing - Filings
- 23 days ago - Gossamer Bio announces early tender results, early settlement of solicitation - TheFly
- 23 days ago - Gossamer Bio, Inc. Announces Early Tender Results and Early Settlement for Exchange Offer and Consent Solicitation with Respect to Existing Convertible Notes - Business Wire
- 24 days ago - Gossamer Bio announces extension of early tender date for exchange offer - TheFly
- 24 days ago - Gossamer Bio, Inc. Announces Extension of Early Tender Date for Exchange Offer and Consent Solicitation with Respect to Existing Convertible Notes - Business Wire